Clinical trial
Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients
NCT01134250
Study timeline
Study start (actual)2008-08-06Date precision: day
Registry last updated2022-04-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Solid Tumorunresolved
Breast Cancerunresolved
Metastatic Melanomaunresolved
Non-small Cell Lung Cancer (NSCLC)unresolved
Interventions
Sponsors & collaborators
Philogen S.p.A.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01134250 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.